Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13722007 | 0.90 | PPARG (0.69) | PPARGPPARA | |
| SCHEMBL13721298 | 0.89 | PPARG (0.69) | PPARGPPARA | |
| SCHEMBL13720502 | 0.87 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL9005916 | 0.83 | PPARG (0.73) | PPARGPPARA | |
| SCHEMBL13718226 | 0.83 | PPARG (1.00) | PPARGPPARA | |
| SCHEMBL14339674 | 0.83 | PPARG (0.70) | PPARGPPARA | |
| SCHEMBL13958237 | 0.83 | PPARG (0.67) | PPARGPPARA | |
| SCHEMBL4391054 | 0.82 | PPARG (0.75) | PPARGPPARA | |
| SCHEMBL14339707 | 0.82 | PPARG (0.66) | PPARGPPARA | |
| SCHEMBL13719869 | 0.82 | PPARA (0.75) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7579479-B2 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | BRISTOL-MYERS SQUIBB COMPANY (US) | 2009-08-25 | — | — | US | disclosed |
| US-20070015797-A1 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | CHENG PETER T | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015797-A1 | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | GPR119, LIPC, ACACA | PPARG 65/4885PPARA 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.